Is peanut butter bad for cholesterol
Pro Research Analysisby 
Searched over 200M research papers
The Impact of Peanut Butter on Cholesterol Levels
Introduction to Peanut Butter and Cholesterol
Peanut butter, a popular spread made from ground peanuts, is often scrutinized for its health effects, particularly concerning cholesterol levels. Cholesterol, a fatty substance in the blood, is crucial for building cells but can lead to cardiovascular diseases (CVD) if levels are too high. This article synthesizes findings from multiple studies to determine whether peanut butter is detrimental to cholesterol levels.
Effects of Peanut Butter on Lipid Profiles
Reduction in LDL and Total Cholesterol
Several studies indicate that peanut butter consumption can positively affect cholesterol levels. A randomized clinical trial and meta-analysis found that regular intake of peanut butter significantly reduced total cholesterol and LDL-cholesterol (the "bad" cholesterol) levels in healthy individuals1. This reduction is crucial as high levels of LDL-cholesterol are associated with an increased risk of heart disease.
Increase in HDL Cholesterol
Peanut butter also appears to have a beneficial effect on HDL-cholesterol (the "good" cholesterol). A systematic review and meta-analysis reported that peanut consumption, including peanut butter, significantly increased HDL-cholesterol levels2. Higher HDL levels are beneficial as they help remove other forms of cholesterol from the bloodstream.
Impact on Triglycerides
The same meta-analysis highlighted that peanut consumption is associated with a decrease in triglycerides, another type of fat in the blood that, when elevated, can increase the risk of heart disease1. This finding suggests that peanut butter can contribute to a healthier lipid profile overall.
Comparative Studies on Peanut Forms and Processing
Whole Peanuts vs. Peanut Butter
Research comparing different forms of peanuts, including whole nuts and peanut butter, found no significant differences in their effects on body weight or fasting plasma lipids3. This suggests that the health benefits of peanuts are retained regardless of their form, making peanut butter a convenient and beneficial option.
High-Monounsaturated Fatty Acid Diets
Peanut butter is rich in monounsaturated fatty acids (MUFAs), which are known to lower both total cholesterol and LDL-cholesterol without reducing HDL-cholesterol4. Diets high in MUFAs, including those incorporating peanut butter, have been shown to improve the overall cardiovascular risk profile more effectively than low-fat diets4 6.
Considerations for High-Risk Individuals
Weight Gain Concerns
While peanut butter has many benefits, individuals at high cardiometabolic risk should be cautious. Some studies have noted a slight increase in body weight with higher doses of peanut consumption, although this did not translate to increases in body fat or body mass index1. Therefore, moderation is key, especially for those concerned about weight gain.
Special Populations
In hypercholesterolemic men, short-term peanut consumption significantly improved lipid profiles and reduced the risk of coronary heart disease (CHD)7. This suggests that even those with existing cholesterol issues can benefit from incorporating peanut butter into their diet.
Conclusion
Overall, the evidence suggests that peanut butter is not bad for cholesterol; in fact, it can be beneficial. Regular consumption of peanut butter can lower LDL and total cholesterol levels, increase HDL cholesterol, and reduce triglycerides, contributing to a healthier lipid profile. However, individuals at high cardiometabolic risk should consume it in moderation to avoid potential weight gain. Thus, peanut butter can be a heart-healthy addition to most diets.
Sources and full results
Most relevant research papers on this topic
Effect of Peanut Consumption on Cardiovascular Risk Factors: A Randomized Clinical Trial and Meta-Analysis
Regular consumption of peanuts and peanut butter may reduce triglyceride blood levels, potentially improving cardiometabolic health.
Meta-AnalysisPeanut and cardiovascular disease risk factors: A systematic review and meta-analysis
Peanut consumption has a positive effect on high-density lipoprotein cholesterol, but has no significant effect on other cardiovascular disease risk factors.
Meta-AnalysisEffects of peanut processing on body weight and fasting plasma lipids
Peanut processing does not compromise the lipid-lowering effects and does not negatively impact body weight, regardless of the form or processing used.
RCT
Very Rigorous JournalHigh-monounsaturated fatty acid diets lower both plasma cholesterol and triacylglycerol concentrations.
A high-monounsaturated fatty acid (MUFA) diet may be preferable to a low-fat diet due to its more favorable effects on cardiovascular disease risk profile.
RCT
Highly CitedLow fat and high monounsaturated fat diets decrease human low density lipoprotein oxidative susceptibility in vitro.
High monounsaturated fat diets, such as peanuts and peanut butter, have similar effects on LDL oxidative resistance as lower-fat diets, suggesting that different sources of MUFA can be combined without increasing LDL oxidative susceptibility.
RCTHighly CitedPeanut consumption and cardiovascular risk
Short-term peanut consumption may improve lipid profiles, reduce atherogenic index, and CHD risk in free-living hypercholesterolaemic men.
RCTCholesterol vehicle in experimental atherosclerosis. A brief review with special reference to peanut oil.
Peanut oil's atherogenicity may be due to the structure of its triglyceride or a lectin present in it, rather than its saturated fat content.
Regular consumption of nuts is associated with a lower risk of cardiovascular disease in women with type 2 diabetes.
Frequent nut and peanut butter consumption is associated with a significantly lower cardiovascular disease risk in women with type 2 diabetes.
Observational StudyVery Rigorous JournalHighly CitedThe role of tree nuts and peanuts in the prevention of coronary heart disease: multiple potential mechanisms.
Nut and peanut consumption reduces coronary heart disease risk and associated risk factors, with a 35% reduced risk in the highest intake group.
Highly Cited